InsidersTradesSigma
Nuo Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the Nuo Therapeutics, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Nuo Therapeutics, Inc. has logged 23 insider filings. Market capitalisation: €50.3m. The latest transaction was filed on 4 August 2025 (Levée d'options). Among the most active insiders: Pittman Scott M.. All data is openly available.
23
Insider Decl.
0
Thresholds
€1m
6 ops.
Buy Volume
€44,639
1 ops.
Sell Volume
36Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,988 of 26,282 companies
33.7
score / 100
Value25
Quality42
FCF yld-2.3%
Earn yld-5.0%
EV/EBITDA·
ROE·
Gross mgn67%
Net mgn-76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 August 2025
Declarations23 total
120,313 shares@ US$0.40Common StockSEC:0001437749-25-024508:0
120,313 shares@ US$0.40Common StockSEC:0001437749-25-024505:0
87,500 shares@ US$0.40Common StockSEC:0001437749-25-024499:0
100,000 shares@ US$0.40Common StockSEC:0001437749-25-024497:0
183,853 shares@ US$0.40Common StockSEC:0001437749-25-024493:0
3,946 shares@ US$1.50Common StockSEC:0001437749-25-024429:0
133,333 shares@ US$1.50Common StockSEC:0001437749-25-024427:0
Ideal exit: 26 Apr 2026 (T+270)
121,875 shares@ US$0.406.7% of flowCommon StockSEC:0001437749-24-035771:0
125,000 shares@ US$0.757.7% of flowCommon StockSEC:0001437749-24-029634:0
Ideal exit: 15 Jun 2025 (T+270)
100,000 shares@ US$0.756.3% of flowCommon StockSEC:0001437749-24-017815:0
Ideal exit: 14 Feb 2025 (T+270)
15,000 shares@ US$0.7511.7% of flowCommon StockSEC:0001437749-24-017814:0
135,000 shares@ US$0.7513.5% of flowCommon StockSEC:0001437749-24-017813:0
150,000 shares@ US$0.506.2% of flowCommon StockSEC:0001437749-23-034984:0
Ideal exit: 14 Sept 2024 (T+270)
20,000 shares@ US$0.5010.3% of flowCommon StockSEC:0001437749-23-034982:0
600,000 shares@ US$0.5039.7% of flowCommon StockSEC:0001437749-23-034980:0
62,500 shares@ US$2.0010.3% of flowCommon StockSEC:0001437749-23-022109:0
Ideal exit: 27 Apr 2024 (T+270)
25,000 shares@ US$2.0051.2% of flowCommon StockSEC:0001437749-23-021950:0
100,000 shares@ US$2.0026.3% of flowCommon StockSEC:0001437749-23-021946:0
30,000 shares@ US$1.5081.7% of flowCommon StockSEC:0001437749-22-027386:0
10,532 shares@ US$1.000.017% mcap100.0% of flowCommon StockSEC:0001437749-22-010382:0
804,868 shares@ US$1.001.27% mcap100.0% of flowCommon StockSEC:0001437749-22-010378:0
Ideal exit: 24 Jan 2023 (T+270)
25,000 shares@ US$1.000.039% mcap100.0% of flowCommon StockSEC:0001437749-22-010381:0
100,000 shares@ US$1.000.16% mcap100.0% of flowCommon StockSEC:0001437749-22-010379:0
23 of 23 declarations
About Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. is a biotechnology company focused on developing treatments for chronic diseases. It aims to provide innovative solutions to enhance patient health.